A Pilot Study Assessing Efficacy, Safety, and Tolerability of EmSam [selegiline] in Bipolar Depression.
Phase of Trial: Phase IV
Latest Information Update: 14 May 2013
At a glance
- Drugs Selegiline (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- 17 Jan 2008 Status changed from recruiting to suspended due to "current lack of medication support".
- 05 Nov 2007 New trial record.